Gilead Sciences, Inc. (SNSE:GILD)

Gilead Sciences Ratios and Metrics

Market cap in millions CLP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	144,875,042	114,394,639	88,496,733	91,476,854	77,600,831	51,888,206
Market Cap Growth	25.39%	29.26%	-3.26%	17.88%	49.55%	-16.06%
Enterprise Value	158,201,973	130,759,220	102,331,217	106,496,049	94,622,939	53,508,856
Last Close Price	102471.31	86956.90	53751.82	49743.39	47701.42	33071.67
PE Ratio	18.58	239.83	17.82	23.45	14.63	593.74
PS Ratio	5.18	4.00	3.72	3.95	3.34	2.96
PB Ratio	7.02	5.98	4.44	5.08	4.32	4.01
P/FCF Ratio	16.44	11.17	13.60	12.91	8.43	9.71
P/OCF Ratio	15.58	10.63	12.61	11.87	8.00	8.94
EV/Sales Ratio	5.86	4.58	4.31	4.60	4.07	3.05
EV/EBITDA Ratio	11.92	9.78	9.75	9.59	7.94	6.05
EV/EBIT Ratio	14.99	12.31	12.58	11.42	9.31	6.87
EV/FCF Ratio	17.96	12.77	15.73	15.02	10.28	10.02
Debt / Equity Ratio	1.16	1.42	1.13	1.22	1.30	1.76
Debt / EBITDA Ratio	1.74	2.01	2.11	1.95	1.93	2.55
Debt / FCF Ratio	2.72	2.65	3.46	3.09	2.53	4.27
Asset Turnover	0.52	0.48	0.43	0.42	0.40	0.38
Inventory Turnover	3.39	3.58	3.66	3.62	3.35	2.83
Quick Ratio	1.11	1.33	1.15	1.03	1.02	1.20
Current Ratio	1.45	1.60	1.43	1.29	1.27	1.40
Return on Equity (ROE)	40.71%	2.29%	25.54%	21.60%	31.57%	0.44%
Return on Assets (ROA)	12.57%	11.03%	9.25%	10.46%	10.94%	10.54%
Return on Capital (ROIC)	16.14%	14.07%	12.15%	14.38%	15.11%	13.94%
Return on Capital Employed (ROCE)	24.60%	22.70%	18.20%	21.10%	21.20%	19.20%
Earnings Yield	5.38%	0.42%	5.61%	4.26%	6.83%	0.17%
FCF Yield	6.08%	8.95%	7.35%	7.75%	11.86%	10.29%
Dividend Yield	2705.02%	3.52%	4.89%	4.99%	5.07%	5.84%
Payout Ratio	49.10%	816.25%	67.24%	80.77%	57.91%	2804.07%
Buyback Yield / Dilution	-1.02%	0.24%	0.32%	0.08%	0.08%	1.10%
Total Shareholder Return	2704.00%	3.76%	5.21%	5.07%	5.15%	6.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.